Data / Drug companies / Akron Pharma Inc.
Akron Pharma Inc.: 60 products in the FDA NDC directory, labeler code 71399
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Akron Pharma Inc. (labeler code 71399) lists 60 products in the FDA National Drug Code Directory, covering 36 finished drugs by generic name. By type: 48 over the counter drugs, 12 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 26, 2025.
The request: Watch Akron Pharma Inc. (FDA labeler code 71399): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71399
- Products in commercial distribution
- 60
- Packages
- 129
- Finished drugs by generic name
- 36
- Prescription products
- 12
- Over the counter products
- 48
- Flagged as original packager
- 60 of 60 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- December 26, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 46 | 76.7% |
| Other unapproved drugs | 11 | 18.3% |
| Generic drugs (ANDA) | 3 | 5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 48 | 80% |
| Prescription drugs | 12 | 20% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Sulfacetamide sodium, sulfur | 6 | 13 |
| Benzoyl peroxide | 4 | 82 |
| Lidocaine | 3 | 216 |
| Acetaminophen | 3 | 214 |
| Diphenhydramine hcl | 3 | 99 |
| Childrens acetaminophen | 2 | 3 |
| Dextromethorphan hbr, guaifenesin | 2 | 67 |
| Guaifenesin | 2 | 123 |
| Urea | 2 | 17 |
| Magnesium citrate | 2 | 29 |
| Hydrocortisone | 2 | 171 |
| Sodium sulfacetamide | 2 | 10 |
| Children acetaminophen | 2 | 1 |
| Camphor, menthol, methyl salicylate | 2 | 36 |
| Fexofenadine hcl | 2 | 39 |
| Hydroquinone | 1 | 12 |
| Medpura vitamin a and d | 1 | 1 |
| Camphor (synthetic), eucalyptus oil, and menthol | 1 | 10 |
| Calcium carbonate | 1 | 101 |
| Miconazole nitrate | 1 | 101 |
| Hydrophor | 1 | 1 |
| Zinc oxide, menthol | 1 | 2 |
| Aspirin | 1 | 134 |
| Dibucaine | 1 | 3 |
| Lidocaine 4% with menthol 1% | 1 | 1 |
| Sennosides | 1 | 65 |
| Antacid calcium carbonate | 1 | 4 |
| Witch hazel | 1 | 63 |
| Menthol and methyl salicylate | 1 | 7 |
| Senna | 1 | 6 |
| Medpura zinc oxide 20% | 1 | 1 |
| Bisacodyl | 1 | 60 |
| Simethicone | 1 | 86 |
| Clotrimazole | 1 | 98 |
| Clotrimazole topical solution usp, 1% | 1 | 5 |
| Menthol | 1 | 263 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 16 | 26.7% |
| Cream | 7 | 11.7% |
| Ointment | 6 | 10% |
| Suspension | 5 | 8.3% |
| Patch | 5 | 8.3% |
| Tablet | 4 | 6.7% |
| Solution | 4 | 6.7% |
| Capsule | 2 | 3.3% |
| Lotion | 2 | 3.3% |
| Gel | 2 | 3.3% |
| Tablet, chewable | 2 | 3.3% |
| Tablet, coated | 1 | 1.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Regular strength antacid peppermint | 71399-9940 | Tablet, chewable | Over the counter monograph drugs | September 26, 2025 |
| Regular Strength Assorted Flavors | 71399-9939 | Tablet, chewable | Over the counter monograph drugs | September 23, 2025 |
| Dibucaine | 71399-2829 | Ointment | Over the counter monograph drugs | January 6, 2025 |
| Hydrocortisone | 71399-0180 | Cream | Over the counter monograph drugs | January 6, 2025 |
| RectoProtect | 71399-0050 | Cream | Over the counter monograph drugs | January 6, 2025 |
| Asper Flex | 71399-0049 | Cream | Over the counter monograph drugs | January 6, 2025 |
| Diphenhydramine HCl | 71399-1028 | Capsule | Over the counter monograph drugs | December 6, 2024 |
| Diphenhydramine HCl | 71399-1027 | Capsule | Over the counter monograph drugs | December 6, 2024 |
| Acetaminophen | 71399-1026 | Tablet | Over the counter monograph drugs | December 6, 2024 |
| Acetaminophen | 71399-1025 | Tablet | Over the counter monograph drugs | December 6, 2024 |
| Senna | 71399-1017 | Tablet | Over the counter monograph drugs | December 6, 2024 |
| Low Dose Aspirin | 71399-1014 | Tablet, coated | Over the counter monograph drugs | December 6, 2024 |
| MICONAZOLE Nitrate 2% | 71399-0071 | Cream | Over the counter monograph drugs | November 19, 2024 |
| MEDPURA Benzoyl Peroxide Aqueous Base, Acne Treatment Gel | 71399-9478 | Gel | Over the counter monograph drugs | September 13, 2024 |
| MEDPURA Benzoyl Peroxide Aqueous Base, Acne Treatment Gel | 71399-9474 | Gel | Over the counter monograph drugs | September 13, 2024 |
| MEDPURA Benzoyl Peroxide | 71399-9236 | Liquid | Over the counter monograph drugs | September 13, 2024 |
| MEDPURA Benzoyl Peroxide | 71399-9234 | Liquid | Over the counter monograph drugs | September 13, 2024 |
| OneLAX | 71399-8460 | Suppository | Over the counter monograph drugs | September 13, 2024 |
| Urea Cream 40% | 71399-8456 | Cream | Other unapproved drugs | September 13, 2024 |
| Urea | 71399-8455 | Lotion | Other unapproved drugs | September 13, 2024 |
| AsperFlex | 71399-6854 | Cream | Over the counter monograph drugs | September 13, 2024 |
| Hydroseptine | 71399-6743 | Ointment | Over the counter monograph drugs | September 13, 2024 |
| Hydrophor | 71399-5101 | Ointment | Over the counter monograph drugs | September 13, 2024 |
| Vaporx | 71399-4589 | Ointment | Over the counter monograph drugs | September 13, 2024 |
| Sodium sulfacetamide | 71399-1599 | Shampoo | Other unapproved drugs | September 13, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.